Abhijit Banerjee is a Professor in the Department of Economics at the Massachusetts Institute of Technology (MIT). His research focuses on development economics, public health policy, and social protection programs, particularly addressing poverty and inequality in low- and middle-income countries. He has conducted large-scale experiments evaluating interventions such as conditional cash transfers, universal basic income, and healthcare policies. Key areas of interest include the design and implementation of anti-poverty programs, behavioral economics, and the long-term health impacts of infectious diseases like COVID-19. His work often integrates experimental methods to assess policy effectiveness, with contributions to global health studies and economic development strategies. Notably, his research on the RECOVERY trial evaluates treatments for hospitalized COVID-19 patients, while other studies explore financial spillover effects of electronic government transfers in Indonesia and savings behavior interventions in Chile. Banerjee has collaborated on projects analyzing post-COVID-19 health outcomes, labor market dynamics in India, and the role of trusted messengers in public health communication during crises. Despite the breadth of his contributions, specific details about his educational background, grants, or lab affiliations are not explicitly provided in the source text.
Dr. Sudie E. Back is a Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC), College of Medicine. She also serves as Director of the NIH-sponsored Drug Abuse Research Training (DART) program and is a Staff Psychologist at the Ralph H. Johnson VA's STAR program. Her expertise lies in treating substance use disorders and PTSD, particularly among veterans and civilians. She leads both behavioral and pharmacological clinical trials, as well as neuroimaging studies. Education: PhD in Clinical Psychology from the University of Georgia (2004), clinical internship at Yale University School of Medicine (2002–2003), and postdoctoral training at MUSC (2004–2005). Research Interests: Co-occurring substance use and PTSD, trauma-focused therapies, veterans' mental health. Funding: NIH, Department of Defense, and VA grants, including K23, R01, K02, and a Fulbright award. Dr. Back has pioneered integrated treatment approaches, such as combining oxytocin with exposure therapy for AUD and PTSD. She also developed COPEWeb , a web-based training program for providers treating PTSD and SUD. Her trials include randomized clinical trials on cognitive processing therapy and relapse prevention. Awards: Career Development Award (K23) R01 grants Independent Scientist Award (K02) Fulbright Scholar Award (Australia) Labs/Teams: Director of DART program at MUSC and STAR program at the VA, focusing on translational research and clinical training.
Dr. Amin Keramati is an Assistant Professor of Supply Chain Management at Widener University’s School of Business Administration. He holds a PhD in Transportation & Logistics from North Dakota State University and previously served as a graduate research assistant at the Upper Great Plains Transportation Institute. His work includes federally funded projects like the Mountain-Plains Consortium’s MPC-550 project, focusing on highway-rail grade crossing safety. Dr. Keramati teaches courses in enterprise resource planning, decision analytics, database management, transportation/logistics, project management, and data analytics. Education: PhD in Transportation & Logistics, North Dakota State University Graduate Research Assistant at Upper Great Plains Transportation Institute Research Focus: Dr. Keramati develops mathematical, statistical, and machine learning approaches to solve complex problems in transportation, supply chain, and logistics. Key areas include data mining, big data decision support, transportation network analytics, project scheduling, smart manufacturing, and accident analysis. His interdisciplinary work bridges supply chain optimization with emerging technologies like blockchain for healthcare and clinical trials. Awards & Recognition: Student Paper Award, American Association of State Highway and Transportation Officials (2017) Grants & Projects: Lead researcher on the Mountain-Plains Consortium’s MPC-550 project, which expanded his dissertation work on safety systems for highway-rail crossings. Collaborates on federally funded transportation safety initiatives and supply chain optimization for bioethanol and pharmaceutical industries. Labs/Teams: Active in Widener’s School of Business research groups focusing on supply chain innovation and interdisciplinary projects combining logistics with emerging technologies.
Vincent Quagliarello, MD, is Professor of Medicine in the Department of Infectious Diseases at Yale School of Medicine, where he also serves as Clinical Chief of Infectious Diseases and Vice Chair for Education and Academic Affairs in the Department of Internal Medicine. His research focuses on infections among older adults, with particular expertise in endocarditis, meningitis, and antimicrobial stewardship in geriatric populations. Dr. Quagliarello has been an NIH R01-funded principal investigator studying infections in older adults and received an NIH K07 Academic Leadership Award to mentor postdoctoral trainees and junior faculty. His publication record demonstrates consistent focus on antimicrobial use in elderly patients, particularly those with advanced cancer, nursing home residents, and end-of-life care scenarios. His research has significantly contributed to understanding appropriate antimicrobial therapy in geriatric populations and the management of infections in complex elderly patients. Scientific Awards: Clinical Teacher Award (2011) from Infectious Diseases Society of America Leah Lowenstein Award (2007) from Yale School of Medicine Department of Internal Medicine Teacher of the Year (1998, 1990) Laureate Award (1997) from American College of Physicians (CT Chapter) Bohmfalk Teaching Prize (1997) from Yale School of Medicine Dr. Quagliarello has served as an educational leader at Yale, directing the Internal Medicine Clerkship, the Yale Infectious Diseases Fellowship program, and creating the Department of Medicine Research in Residency Program. His clinical work spans the spectrum of infectious diseases with a special focus on public health impact.
Martin T. Wells is the Charles A. Alexander Professor of Statistical Sciences at Cornell University, with joint appointments in the Department of Statistical Science, Department of Biological Statistics and Computational Biology, Department of Social Statistics, and as Professor of Clinical Epidemiology and Health Services Research at Weill Medical School. He serves as Editor-in-Chief of the ASA-SIAM Book Series and Co-Editor of the Journal of Empirical Legal Studies. Cornell University, Ithaca, NY Weill Cornell Medical College Research Interests span applied and theoretical statistics, Bayesian methods, biostatistics, clinical epidemiology, and computational biology. His work bridges disciplines like finance, legal studies, and health services research. Article Trends highlight advancements in Bayesian modeling, quantum cognition machine learning, tensor analysis, and misclassification correction, with applications in genomics, finance, and public health. Fellow of the American Statistical Association Fellow of the Royal Statistical Society Contributions include developing statistical software (e.g., rTensor), methodological innovations in clinical trials, and empirical legal studies on civil rights and the death penalty.
Allison Ross Eckard, MD is Professor in the Departments of Pediatrics and Medicine at the Medical University of South Carolina (MUSC) College of Medicine, serving as Division Chief for Pediatric Infectious Diseases and Director of MUSC's Ryan White Pediatric HIV Clinic and HIV Transition Clinic. She maintains an adjunct faculty position at Emory University and holds board certification in Pediatrics and Pediatric Infectious Diseases. Her primary research focuses on metabolic, cardiovascular, and nutritional complications of chronic HIV and antiretroviral therapy across age groups, with emphasis on inflammation's role in comorbidities like cardiovascular disease and bone disorders. Current investigations include NIH R01-funded research on interventions for weight gain and abdominal fat in HIV, vitamin D supplementation, and statin therapy. She has published nearly 60 peer-reviewed papers on HIV pathogenesis and treatment optimization. Dr. Eckard co-chairs the DHHS panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children and serves on the DHHS panel for Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV . Her clinical work specializes in comprehensive HIV care for children through young adults, with particular focus on adolescent/young adult transition issues and global health initiatives through Lespwa Timoun in Haiti. Recent efforts include developing COVID-19 treatment guidelines for children and school safety protocols. HIV Specialist certification (American Academy of HIV Medicine) Fellow, Infectious Diseases Society of America Fellow, Pediatric Infectious Diseases Society Fellow, HIV Medical Association Member, HIV Medical Association's 'Ending the HIV Epidemic' working group She leads MUSC's HIV education initiatives and serves as inpatient consultant for pediatric infectious diseases, with advanced training in tropical medicine. Her NIH-funded research examines targeted interventions to minimize comorbidity development in HIV, while her clinical leadership spans the Ryan White HIV program, transition clinics, and global health partnerships.
Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.
Colleen Conley is a Clinical Professor in the Department of Psychology at Loyola University Chicago, specializing in clinical psychology with a focus on adolescent and emerging adult mental health. She directs the IMPACT (Improving Mental-health and Promoting Adjustment through Critical Transitions) Lab, which conducts research on psychological well-being during developmental transition periods. Dr. Conley earned her Ph.D. from the University of Illinois at Urbana-Champaign and her B.A. from Lawrence University. Her research program blends observational studies, meta-analyses, and intervention development to improve well-being, particularly during critical life transitions like the college years. Her work examines psychological trajectories in adolescence and emerging adulthood, with special attention to gender issues and LGBTQIA+ well-being. Her research interests center on developmental psychopathology, examining the interplay between individuals and their contexts over time. She investigates how biological, psychological, cognitive, and social factors interact to influence psychological distress and well-being. Much of her work focuses on college student mental health, including trajectories of well-being during the transition to college and interventions to address mental health challenges. Analysis of her recent publications reveals a strong focus on college student mental health, with emphasis on developmental trajectories, intervention effectiveness (particularly peer-led and technology-delivered approaches), and the impact of transition periods on psychological functioning. Her work increasingly incorporates digital interventions and examines moderators of intervention effectiveness across diverse student populations. Research Mentoring Award Program recognition for mentoring award-winning students Heckler Summer Research Fellowship recognition for mentoring fellowship recipients Dr. Conley mentors numerous graduate students in the clinical psychology program, with many completing dissertations on topics related to mental health interventions, student well-being, and developmental transitions. Her IMPACT Lab collaborates with university staff, administrators, and other researchers to develop practical interventions that address student mental health needs. Current projects include Honest, Open, Proud (HOP) for stigma reduction, Wellness Advising with Motivational Interviewing (WAMI), Students Taking on Effective Post-Graduate Skills (STEPS), and Supportive Accountability Methods for Mentoring Young Adults (SAMMY-A). The lab also partners with commercial entities like Headspace for mindfulness research.
Lyle Ungar is a Professor at the Department of Computer and Information Science at the University of Pennsylvania . He is affiliated with multiple graduate groups, including Genomics and Computational Biology in the School of Medicine , Operations, Information and Decisions in the Wharton School , and Psychology in the School of Arts and Sciences . His research focuses on explainable machine learning , deep learning , and natural language processing for psychology and medical research , analyzing social media and sensor data to understand well-being, empathy, and stress. His work spans bioinformatics , applied economics , and group decision-making . Recent publications examine LLM-based tutoring , cross-cultural translation , and AI in palliative care , showing trends in reinforcement learning , mobile health , and health data analytics . He has contributed to Google Scholar , PubMed , and DBLP with over 15 papers since 2023. Scientific Awards : 2019 Alan I. Leshner Leadership Institute Public Engagement Fellow His students include Vitoria Aquino Guardieiro , Yihao Li , and co-advised researchers like Shreya Havaldar with Eric Wong. He leads projects at interdisciplinary centers such as the Annenberg Public Policy Center , Center for Cognitive Neuroscience , and Institute for Translational Medicine .
Kristin Bernard, Ph.D. (University of Delaware, 2013), is an Associate Professor of Clinical Psychology at Stony Brook University’s Department of Psychology. Her research focuses on the neurobiological consequences of early adversity, parent-child relationships, and the efficacy of early parenting interventions such as Attachment and Biobehavioral Catch-up (ABC). She collaborates with Power of Two, a NYC-based nonprofit, and leads the Developmental Stress and Prevention Lab. Current grants include studies on epigenomics, maternal attachment representation, and community-based ABC interventions. Dr. Bernard’s work bridges clinical and developmental psychology, emphasizing prevention science and translational research. Education: Ph.D. in Clinical Psychology, University of Delaware, 2013. Research Interests: Child maltreatment, neurobiological impacts of early adversity, parenting interventions, psychobiology of attachment, and intervention efficacy. Her lab investigates mechanisms linking caregiving quality to child outcomes, including cortisol regulation, brain development, and behavioral compliance. Lab & Partnerships: Directs the Developmental Stress and Prevention Lab, focusing on high-risk populations. Collaborations include Power of Two for ABC implementation and NYC agencies like the Administration for Children’s Services. Current projects explore neighborhood influences on parenting (Geography of Parenting Study) and neural correlates of parenting behavior (SNAP study). Grants & Funding: Principal Investigator on NIH-funded projects (R03 HD099372, R01 MH119310) and co-PI on Stony Brook’s seed grants. Projects examine accelerated aging biomarkers and intervention effectiveness in community settings. Publications: Over 50 peer-reviewed articles and a co-authored book on ABC interventions. High-impact journals include Psychoneuroendocrinology , Development and Psychopathology , and Child Development .
Jino Distasio is a Professor and Acting Dean of Science at The University of Winnipeg, Department of Geography. He teaches Urban Geography, Cultural Geography, and Social Geography, with courses like GEOG-3413 Urban Revitalization and GEOG-3430 Housing and Neighbourhood Planning . His research focuses on housing and neighborhood development, city planning, urban revitalization, homelessness, mental health, and urban transportation. Teaching Areas : Urban Geography, Cultural Geography, Social Geography Key Collaborations : Institute of Urban Studies (U. of Winnipeg), Housing First initiatives, interdisciplinary teams in public health and social policy His recent publications highlight Housing First interventions, urban policy impacts on homelessness, and social determinants of health. Scientific awards and honors were not explicitly mentioned in the provided text.
Professor Jennifer Whitty is an applied health economist at the University of East Anglia , affiliated with the Norwich Medical School and the Centre of Research Excellence in Telehealth . Her research bridges health economics, patient preferences, and health policy, with a focus on quality of life valuation and economic evaluation. Education: Doctor of Philosophy (Griffith University, 2008), Graduate Diploma in Clinical Pharmacy (University of Queensland, 2002), Bachelor of Pharmacy (University of Wales, 1992) Her work emphasizes person-centered methodologies , particularly discrete choice experiments, to evaluate patient and public preferences for healthcare delivery and outcomes. Key research areas include: Treatment burden and quality of life in chronic diseases like cystic fibrosis Economic evaluation of pharmaceuticals and health technologies Asset-based approaches to community health Priority-setting frameworks in health policy Prof. Whitty has secured over AU$27 million in research funding from organizations including the NHMRC and National Institute for Health and Care Research , and serves on editorial boards for Medical Decision Making and Applied Health Economics and Health Policy .
Bernadka Dubicka is a Clinical Professor and Honorary Clinical Chair in the Division of Neuroscience at the University of Manchester. She holds dual roles as a research lead at Pennine Care NHS Foundation Trust and as the child and adolescent mental health research lead for Health Innovation Manchester. She is the Editor-in-Chief of the Journal of Child and Adolescent Mental Health and previously served as Chair of the Child and Adolescent Faculty at the Royal College of Psychiatrists (2017–2021). Her academic qualifications include a BSc in Psychology and MBBs from University College London, followed by FRCPsych accreditation in child psychiatry. She earned a gold medal for her MD thesis on behavioral disorder implications in depression. Dubicka’s research focuses on adolescent depression, mood disorders, and brief interventions, including the IMPACT and STADIA trials evaluating psychological treatments and standardized diagnostic assessments. Her work also addresses technology’s role in youth mental health and the eco-crisis’s mental health impacts. Education: BSc Psychology, University College London MBBs, University of London MD Thesis (Gold Medal), University College London FRCPsych, Royal College of Psychiatrists Her research spans depression treatment efficacy, behavioral activation, and cross-national studies on pediatric bipolar disorder. She collaborates internationally and has led over 49 publications. Awards include a gold medal for her thesis and recognition as an RCPsych Fellow. Her work also emphasizes policy advocacy, such as addressing digital rights for children and mental health responses to climate change (e.g., COP26 contributions). She trains clinicians in brief psychosocial interventions and behavioral activation through academic programs and national courses. Grants & Funding: Co-investigator on the £1.1M HTA-funded STADIA trial evaluating remote mental health assessments. Principal investigator on the IMPACT trial, one of the largest adolescent depression trials globally. Labs/Teams: Collaborations include the University of Cambridge (IMPACT trial), University of Nottingham (STADIA), and international taskforces on treatment-resistant depression.
Jeppe Bennekou Schroll serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, based at Blegdamsvej 3, 2200 Copenhagen N, Denmark. His research expertise spans: Gynecology and Obstetrics Cervical Cancer Screening methodologies HPV Vaccination impact assessment Women's Urological Health Elderly Women's Gynecological Care Population-based Medical Research Dr. Schroll's 2025 publications demonstrate a concentrated focus on evidence-based gynecological interventions using Danish population data. His work bridges clinical practice and public health through cohort studies on HPV vaccination efficacy, surgical outcomes in elderly patients, and innovative non-surgical treatments for urinary incontinence. The research consistently employs robust methodologies including population registries and randomized controlled trials, with significant media coverage across 14 news outlets and social platforms.
Susan A. Murphy is the Mallinckrodt Professor of Statistics and of Computer Science at Harvard University, with affiliations to the Kempner Institute. She leads the Statistical Reinforcement Learning Lab, focusing on developing algorithms to inform sequential decision-making in health, particularly for Just-in-Time Adaptive Interventions (JITAIs) and micro-randomized trials (MRTs). Her work is funded by NIH institutes, including NIDA, NHLBI, and NIBIB. Dr. Murphy has been awarded a MacArthur Fellowship (2013) and is a member of the National Academy of Medicine (2014) and the National Academy of Sciences (2016). Her research integrates statistical methods with computer science techniques to optimize mobile health interventions. She collaborates with d3Lab and mDOT on projects like HeartSteps and Sense2Stop, evaluating real-time treatment policies. Notable contributions include advancing MRT designs, sample size calculations, and reinforcement learning algorithms for personalized healthcare. Dr. Murphy advises a large team of postdocs, graduate students, and undergraduates, many of whom hold academic and industry roles globally. She emphasizes engagement in digital interventions, balancing personalization with ethical considerations. Her lab’s work spans algorithm development, clinical trial design, and causal inference, aiming to improve health outcomes through adaptive interventions.
